Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00005598 · COMPLETED

Trial details

NCT number: NCT00005598
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2000-10-01
Primary completion: 2001-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.